Challenges and Solutions in Early-Phase Oncology Trials

This white paper discusses the challenges faced in early-phase oncology clinical trials, focusing on patient recruitment, regulatory complexities, data management, and financial sustainability. It outlines the pressing issue of patient recruitment, noting that strict eligibility criteria limit participation rates, particularly in low- and middle-income countries. The paper emphasizes the need for broader eligibility criteria to include a more diverse patient population without compromising safety. It also examines the regulatory maze that complicates trial initiation and execution, suggesting a streamlined approach to compliance. The increasing volume of data generated in these trials necessitates robust data management solutions, which are often lacking at trial sites. Furthermore, the financial sustainability of early-phase trials is threatened by low patient enrollment and lengthy negotiations between sponsors and sites. The paper calls for collaborative efforts among stakeholders to address these issues and ensure the viability of oncology trials.